Informatie:
Fout:
ID
12578
Beschrijving
Neutrophil Gelatinase-Associated Lipcalin (NGAL) Evaluation Along With B-Type Natriuretic Peptide in Acutely Decompensated HF; ODM derived from: https://clinicaltrials.gov/show/NCT00693745
Link
https://clinicaltrials.gov/show/NCT00693745
Trefwoorden
Versies (1)
- 02-12-15 02-12-15 -
Geüploaded op
2 december 2015
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Acute Decompensated Heart Failure NCT00693745
Eligibility Acute Decompensated Heart Failure NCT00693745
- StudyEvent: Eligibility
Similar models
Eligibility Acute Decompensated Heart Failure NCT00693745
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Patient sex and age
Item
male or female 18 years of age or older.
boolean
C0150831 (UMLS CUI [1,1])
C0001779 (UMLS CUI [1,2])
C0001779 (UMLS CUI [1,2])
patients presenting to the emergency department / hospital with symptoms of new or decompensated heart failure and who will be treated with at least one dose of iv diuretic
Item
patients presenting to the emergency department / hospital with symptoms of new or decompensated heart failure and who will be treated with at least one dose of iv diuretic;
boolean
C0562508 (UMLS CUI [1])
C0581377 (UMLS CUI [2])
C3898697 (UMLS CUI [3])
C0581377 (UMLS CUI [2])
C3898697 (UMLS CUI [3])
blood samples for baseline ngal, bnp and creatinine levels
Item
ability to draw blood samples for baseline ngal, bnp and creatinine levels either prior to the administration of the first dose of iv diuretic or within 1 hour after the first dose of an iv diuretic
boolean
C0190979 (UMLS CUI [1])
C0748313 (UMLS CUI [2])
C0748313 (UMLS CUI [2])
informed consent
Item
ability to provide written informed consent from subject or their authorized representative.
boolean
C0021430 (UMLS CUI [1])
acute myocardial infarction or active ischemia
Item
acute myocardial infarction or active ischemia ;
boolean
C0155626 (UMLS CUI [1])
C0151744 (UMLS CUI [2])
C0151744 (UMLS CUI [2])
patients who are intubated or otherwise not able to communicate or comply with study assessments
Item
patients who are intubated or otherwise not able to communicate or comply with study assessments
boolean
C0525058 (UMLS CUI [1])
C0439801 (UMLS CUI [2])
C0009488 (UMLS CUI [3])
C0439801 (UMLS CUI [2])
C0009488 (UMLS CUI [3])
cardiogenic shock or any other clinical condition that would contraindicate the administration of an iv agent with potent vasodilating properties
Item
cardiogenic shock or any other clinical condition that would contraindicate the administration of an iv agent with potent vasodilating properties
boolean
C0525058 (UMLS CUI [1])
C0439801 (UMLS CUI [2])
C0009488 (UMLS CUI [3])
C0439801 (UMLS CUI [2])
C0009488 (UMLS CUI [3])
marked renal insufficiency, on dialysis or in imminent need of dialysis
Item
known history of marked renal insufficiency (e.g., usual serum creatinine ≥ 3.0 mg/dl), on dialysis (either acute of chronic) or in imminent need of dialysis at enrollment;
boolean
C1536070 (UMLS CUI [1])
C0011946 (UMLS CUI [2])
C0011946 (UMLS CUI [2])
vulnerable individuals
Item
prisoners or other institutionalized or vulnerable individuals;
boolean
C0949366 (UMLS CUI [1])
participation in another interventional clinical study
Item
participation in an interventional clinical study within the previous 30 days;
boolean
C2348568 (UMLS CUI [1])
unlikely to be willing or able to comply with study procedures
Item
unlikely to be willing or able to comply with study procedures, including the follow-up at 30 and 90 days .
boolean
C1321605 (UMLS CUI [1])